Nobuko Tamura

Association Between a Refined Multidisciplinary Team-Based Care Model and Scalp Cooling Efficacy for Chemotherapy-Induced Alopecia Outcomes Among Breast Cancer Patients: A Single-Institution Retrospective Before–After Study

Nobuko Tamura, Yukiko Nagaoka, Yukari Sano, Yôko Kobayashi et autres

jp (code pays fourni par la source)

Exploratory analysis of prognostic value of ctDNA monitoring among advanced breast cancer with oligometastatic disease: An ancillary biomarker study of JCOG 2110 (JCOG2110A1).

Takahiro Kogawa, Noriko Mitome, Toshiyuki Ishiba, Ikuno Nishibuchi et autres

jp (code pays fourni par la source)

537P Final survival outcomes of eribulin mesylate in combination with trastuzumab and pertuzumab as first-line chemotherapy for HER2-positive, locally advanced or metastatic breast cancer: Results of the randomized, non-inferiority phase 3 JBCRG-M06/EMERALD study

Shigehira Saji, J. Tsurutani, N Masuda, Yoshiatsu Sagara et autres

jp (code pays fourni par la source)

Health-related quality of life and physical activity collected via mobile application and wearable device in patients with HR +/HER2 − advanced breast cancer treated with palbociclib plus endocrine therapy or endocrine therapy alone: 6-month longitudinal study (JBCRG-26)

Hiroko Bando, Aya Ueda, Kaori Terata, Mihoko Doi et autres

jp, us (code pays fourni par la source)

Abstract P4-10-03: Potential risk factors for health-related quality of life (HRQoL) in palbociclib (PAL) plus endocrine therapy (ET) and ET alone patients with HR+/HER2- advanced breast cancer (ABC): exploratory analysis from 6-month longitudinal study (JBCRG-26)

Shigehira Saji, Mari S. Oba, Aya Ueda, Kaori Terata et autres

Abstract PS6-08: Quality of life following total mastectomy, breast-conserving surgery, and immediate breast reconstruction in patients with breast cancer: A multicenter cross-sectional study

Hirohito Seki, Maho Kato, Takako Komiya, Nobuko Tamura et autres

A Case of Fibroadenoma with Squamous Metaplasia

Aya Nishikawa, Keiichi Kinowaki, Akio Shibata, Kiyo Tanaka et autres

jp (code pays fourni par la source)

A Fact-Finding Survey of the Concerns of Patients with Cancer: A Network Analysis

Kazumasa Yamamoto, Yuko Tanabe, Kiyomi Nonogaki, Hiroki Okumura et autres

jp (code pays fourni par la source)

Development of a nomogram to predict recurrence scores obtained using Oncotype DX in Japanese patients with breast cancer

Akio Shibata, Nobuko Tamura, Keiichi Kinowaki, Aya Nishikawa et autres

jp (code pays fourni par la source)

Development of a nomogram to predict recurrence scores obtained using Oncotype DX in Japanese patients with breast cancer

Akio Shibata, Nobuko Tamura, Keiichi Kinowaki, Aya Nishikawa et autres

jp (code pays fourni par la source)

Abstract PO1-05-06: Health-related QOL and physical activity collected via wearable device in patients with HR+/HER2− advanced breast cancer in Japan treated with palbociclib+endocrine therapy (ET) or ET alone: 6-month longitudinal study (JBCRG-26)

Hiroko Bando, Mari S. Oba, Aya Ueda, Kaori Terata et autres

jp (code pays fourni par la source)

Comparison of proportions and prognostic impact of pathological complete response between evaluations of representative specimen and total specimen in primary breast cancer after neoadjuvant chemoradiotherapy: An ancillary study of JCOG0306

Tadahiko Shien, Hitoshi Tsuda, Keita Sasaki, Junki Mizusawa et autres

jp, us, sg, gb (code pays fourni par la source)